State Street’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367M | Buy |
10,194,938
+678,810
| +7% | +$24.5M | 0.01% | 632 |
|
|
2025
Q1 | $296M | Sell |
9,516,128
-244,035
| -3% | -$7.6M | 0.01% | 693 |
|
|
2024
Q4 | $249M | Buy |
9,760,163
+243,901
| +3% | +$6.22M | 0.01% | 808 |
|
|
2024
Q3 | $269M | Buy |
9,516,262
+29,451
| +0.3% | +$833K | 0.01% | 749 |
|
|
2024
Q2 | $250M | Buy |
9,486,811
+386,663
| +4% | +$10.2M | 0.01% | 742 |
|
|
2024
Q1 | $276M | Buy |
9,100,148
+226,598
| +3% | +$6.88M | 0.01% | 711 |
|
|
2023
Q4 | $249M | Buy |
8,873,550
+447,934
| +5% | +$12.6M | 0.01% | 737 |
|
|
2023
Q3 | $229M | Buy |
8,425,616
+238,778
| +3% | +$6.48M | 0.01% | 707 |
|
|
2023
Q2 | $252M | Sell |
8,186,838
-153,967
| -2% | -$4.73M | 0.01% | 690 |
|
|
2023
Q1 | $301M | Buy |
8,340,805
+220,923
| +3% | +$7.96M | 0.02% | 623 |
|
|
2022
Q4 | $321M | Buy |
8,119,882
+198,467
| +3% | +$7.84M | 0.02% | 599 |
|
|
2022
Q3 | $318M | Buy |
7,921,415
+276,675
| +4% | +$11.1M | 0.02% | 584 |
|
|
2022
Q2 | $321M | Sell |
7,644,740
-117,832
| -2% | -$4.95M | 0.02% | 592 |
|
|
2022
Q1 | $302M | Buy |
7,762,572
+685,242
| +10% | +$26.7M | 0.02% | 680 |
|
|
2021
Q4 | $282M | Buy |
7,077,330
+1,242,585
| +21% | +$49.5M | 0.01% | 708 |
|
|
2021
Q3 | $211M | Buy |
5,834,745
+967,111
| +20% | +$35M | 0.01% | 810 |
|
|
2021
Q2 | $200M | Buy |
4,867,634
+181,771
| +4% | +$7.45M | 0.01% | 851 |
|
|
2021
Q1 | $204M | Buy |
4,685,863
+2,328,121
| +99% | +$102M | 0.01% | 793 |
|
|
2020
Q4 | $118M | Buy |
2,357,742
+1,339,548
| +132% | +$67M | 0.01% | 1024 |
|
|
2020
Q3 | $42.8M | Buy |
1,018,194
+977,394
| +2,396% | +$41.1M | ﹤0.01% | 1573 |
|
|
2020
Q2 | $1.98M | Buy |
+40,800
| New | +$1.98M | ﹤0.01% | 3182 |
|